Addex therapeutics to release q1 2023 financial results and host conference call on may 11, 2023

Geneva, switzerland, may 4 , 2023 – addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it will issue its q1 2023 financial results on thursday, may 11, 2023. tim dyer, ceo and robert lÜtjens, head of discovery – biology, will provide a business update and a review of the addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 cest (15:00 bst / 10:00 edt / 07:00 pdt) the same day.
ADXN Ratings Summary
ADXN Quant Ranking